Pharmacokinetic Study of Paracetamol UNIFLASH (125 MG/1.25 ML)

Phase 1 Completed 32 enrolled Unither Pharmaceuticals, France Raptim Research · collab

NaSingle-groupOpen-labelTreatment

Summary

This study aims to assess the pharmacokinetic profile of a new paracetamol formulation (paracetamol Uniflash 125mg/1.25mL) for buccal use after single dose.

Timeline

Start: 2022-07-22
Primary completion: 2022-07-23
Completion: 2022-07-23

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Acetaminophen	Small molecule	125 mg	Other

Indications

No indication recorded.